These data suggest that pulmonary PCM can be modulated by AhR ligands and are in agreement with those obtained in experimental vulvovaginal candidiasis where anti-fungal immunity and disease severity can be modulated by an AhR agonist via the IL-22-IL-18 crosstalk65. This evidence concerns the gene IL22 and vulvovaginal candidiasis.